Skip to main content

Research Repository

Advanced Search

Browse


Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation (2011)
Journal Article
Maher, S. G., McDowell, D. T., Collins, B. C., Muldoon, C., Gallagher, W. M., & Reynolds, J. V. (2011). Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation. Annals of Surgery, 254(5), 809-816. https://doi.org/10.1097/SLA.0b013e31823699f2

OBJECTIVE: To identify serum-based biomarkers predicting response to neoadjuvant chemoradiotherapy (neo-CRT) in esophageal cancer. PURPOSE: Increasingly, the standard of care for esophageal cancer involves neo-CRT followed by surgery. The identificat... Read More about Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation.